{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T07:56:42Z","timestamp":1725868602298},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,7,26]],"date-time":"2004-07-26T00:00:00Z","timestamp":1090800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Hemodialysis patients are a high\u2010risk group for hepatitis C virus (HCV) infection. Assessment of HCV infection using HCV\u2010RNA assay among dialysis patients is important for the issue of safety and environmental protection. However, polymerase chain reaction (PCR)\u2010based methods are unsuitable for analyzing samples from dialysis patients because the conventional centrifugal extraction method fails to eliminate heparin, a potent inhibitor of PCR. In this study, we evaluated the usefulness of a HCV\u2010RNA extraction method using probes and magnetic particles for hemodialysis patients in comparison with the centrifugal method. The study population consisted of 17 HCV antibody\u2010positive patients undergoing hemodialysis. These 17 patients consisted of 12 HCV carrier patients and five patients with past HCV infection. One hundred and two samples from these patients were measured using the centrifugal and magnetic methods. Moreover, we prepared five standards that included theoretically 5\u2003KIU\/mL of HCV. One was made from non\u2010HD patient's serum and the other four were from hemodialysis patients\u2019 serum. These standards were measured using the two methods. False\u2010negative results were not observed with the magnetic method, but were observed in five out of 102 samples with the centrifugal method. Studies using standard samples revealed that accurate HCV\u2010RNA measurement is achieved using the magnetic method. In conclusion, the present study showed that this magnetic extraction method is a highly reproducible and reliable assay to obtain correct information about the presence of the infective virus itself in the hemodialysis setting. Precise identification of HCV\u2010RNA using this specific method is considered to be useful in preventing HCV infection in hemodialysis units.<\/jats:p>","DOI":"10.1111\/j.1526-0968.2004.00161.x","type":"journal-article","created":{"date-parts":[[2004,7,26]],"date-time":"2004-07-26T11:42:32Z","timestamp":1090842152000},"page":"328-334","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Usefulness of a New Hepatitis C Virus RNA Extraction Method Using Specific Capture Probe and Magnetic Particle in Hemodialysis Patients"],"prefix":"10.1111","volume":"8","author":[{"given":"Motoko","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetoshi","family":"Fujiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kakuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimio","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,7,26]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188084"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/oxfordjournals.aje.a116137","article-title":"Prevalence of antibody to hepatitis C virus in hemodialysis patients","volume":"134","author":"Hayashi J","year":"1991","journal-title":"J Epidemiol"},{"key":"e_1_2_6_4_2","first-page":"36","article-title":"Hepatitis virus infection (HBV and HCV) in chronic Japanese hemodialysis units","volume":"38","author":"Oguchi H","year":"1992","journal-title":"Clin Nephrol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/8.8.744"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.4.1001"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.190"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-12-958"},{"key":"e_1_2_6_9_2","first-page":"589","article-title":"Hepatitis C virus antibody in hemodialysis patients: Prevalence and risk factors","volume":"335","author":"Getzug T","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_6_10_2","first-page":"44","article-title":"Antibody to hepatitis C virus increases with time on hemodialysis","volume":"38","author":"Hardy NM","year":"1992","journal-title":"Clin Nephrol"},{"key":"e_1_2_6_11_2","first-page":"91","article-title":"Examination of HCV infection in hemodialysis patients with HCV\u2010RNA assay using a magnetic extraction method (AmpliCap GT HCV MONITOR Test Kit v2.0 and AmpliCap GT HCV Specimen Preparation Kit v2.0)","volume":"45","author":"Tanaka M","year":"2003","journal-title":"Jpn J Nephrol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02355018"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.525"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1128\/JCM.36.6.1711-1715.1998","article-title":"Hepatitis C virus infection in dialysis centers in the Netherlands: a national survey by serological and molecular methods","volume":"36","author":"Schneeberger PM","year":"1998","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_15_2","first-page":"A146","article-title":"Can hepatitis C virus infection be detected with anti\u2010HCV antibody in hemodialysis patients?","volume":"15","author":"Yanai M","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80673-1"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199701000-00005"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/JCM.38.1.18-21.2000","article-title":"Automated specific capture of hepatitis C virus RNA with probes and paramagnetic particle separation","volume":"38","author":"Miyachi H","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_19_2","first-page":"83","volume-title":"GEMHEP.","author":"Wolfe L","year":"1994"},{"key":"e_1_2_6_20_2","first-page":"4171","article-title":"Improbed, Version 2.0. Qualitative and quantitative AMPLICOR reverse transcription\u2010PCR tests for hepatitis C virus RNA. Calibration to international units, enhanced genotype reactivity, and performance characteristics","author":"Lee SC","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6346(00)00069-3"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00698.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000187867"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/11.supp4.36"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91311-U"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-3-199502010-00012"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890430318"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1995.tb01357.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250344"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)91025-D"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90488-3"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-77492-8"},{"key":"e_1_2_6_33_2","first-page":"166","article-title":"Interference of heparin with the polymerase chain reaction","volume":"9","author":"Beutler E","year":"1990","journal-title":"Biotechniques"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1999.7630149.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(90)90145-H"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1526-0968.2004.00161.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1526-0968.2004.00161.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T08:39:28Z","timestamp":1697272768000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1526-0968.2004.00161.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,26]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.1526-0968.2004.00161.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-0968.2004.00161.x","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,26]]}}}